Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Operating Expenses | 1,673 | 1,909 | 7,408 | 2,562 | 326 |
| Operating Income | -1,673 | -1,909 | -7,408 | -2,562 | -326 |
| Interest Expense | 558 | 528 | 135 | 0 | 0 |
| Other Income | 0 | 1 | 1 | 23 | 0 |
| Pre-tax Income | -2,231 | -2,437 | -7,543 | -2,539 | -326 |
| Net Income Continuous | -2,231 | -2,437 | -7,543 | -2,539 | -326 |
| Net Income | $-2,231 | $-2,437 | $-7,543 | $-2,539 | $-326 |
| EPS Basic Total Ops | -4,790.42 | -5,748.50 | -19,640.72 | -10,538.92 | -958.08 |
| EPS Basic Continuous Ops | -5,006.12 | -5,638.40 | -19,527.47 | -10,036.55 | -929.45 |
| EPS Diluted Total Ops | -4,790.42 | -5,748.50 | -19,640.72 | -10,538.92 | -958.08 |
| EPS Diluted Continuous Ops | -5,006.12 | -5,638.40 | -19,527.47 | -10,036.55 | -929.45 |
| EBITDA(a) | $-1,673 | $-1,909 | $-7,275 | $-2,562 | $-326 |